Tenofovir disoproxil hemiedisylate

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTenofovir disoproxil hemiedisylate
Drug Alias NameTenofection
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHuman immunodeficiency virus type 1 reverse transcriptase inhibitorsDNA-directed DNA polymerase inhibitors
TargetsHuman immunodeficiency virus type 1 reverse transcriptaseDNA-directed DNA polymerase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2017/08/01
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesJw Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesJw Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ05AF
Related LinksN/A